Literature DB >> 22778791

Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals?

Jacqueline S Barrett1, Peter R Gibson.   

Abstract

Food intolerance in irritable bowel syndrome (IBS) is increasingly being recognized, with patients convinced that diet plays a role in symptom induction. Evidence is building to implicate fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) in the onset of abdominal pain, bloating, wind and altered bowel habit through their fermentation and osmotic effects. Hypersensitivity to normal levels of luminal distension is known to occur in patients with IBS, with consideration of food chemical intolerance likely to answer many questions about this physiological process. This paper summarizes the evidence and application of the most common approaches to managing food intolerance in IBS: the low-FODMAP diet, the elimination diet for food chemical sensitivity and others including possible noncoeliac gluten intolerance.

Entities:  

Keywords:  FODMAPs; food chemicals; food intolerance; fructose; gluten; irritable bowel syndrome; salicylates

Year:  2012        PMID: 22778791      PMCID: PMC3388522          DOI: 10.1177/1756283X11436241

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN: 1756-283X            Impact factor:   4.409


  43 in total

1.  Self-reported food intolerance in chronic inflammatory bowel disease.

Authors:  M Ballegaard; A Bjergstrøm; S Brøndum; E Hylander; L Jensen; K Ladefoged
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

2.  Role of fructose-sorbitol malabsorption in the irritable bowel syndrome.

Authors:  F Fernandez-Bañares; M Esteve-Pardo; P Humbert; R de Leon; J M Llovet; M A Gassull
Journal:  Gastroenterology       Date:  1991-11       Impact factor: 22.682

3.  Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors.

Authors:  Magnus Simrén; Hasse Abrahamsson; Einar S Björnsson
Journal:  Clin Gastroenterol Hepatol       Date:  2006-12-14       Impact factor: 11.382

4.  Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

Authors:  H M Staudacher; K Whelan; P M Irving; M C E Lomer
Journal:  J Hum Nutr Diet       Date:  2011-05-25       Impact factor: 3.089

5.  Quantification of fructans, galacto-oligosacharides and other short-chain carbohydrates in processed grains and cereals.

Authors:  J R Biesiekierski; O Rosella; R Rose; K Liels; J S Barrett; S J Shepherd; P R Gibson; J G Muir
Journal:  J Hum Nutr Diet       Date:  2011-02-21       Impact factor: 3.089

6.  Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders.

Authors:  J S Barrett; P M Irving; S J Shepherd; J G Muir; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2009-04-15       Impact factor: 8.171

7.  Conservation of mannitol, lactulose, and raffinose by the human colon.

Authors:  D R Saunders; H S Wiggins
Journal:  Am J Physiol       Date:  1981-11

8.  An Australian exclusion diet.

Authors:  A R Gibson; R L Clancy
Journal:  Med J Aust       Date:  1978-03-11       Impact factor: 7.738

9.  Bran and irritable bowel syndrome: time for reappraisal.

Authors:  C Y Francis; P J Whorwell
Journal:  Lancet       Date:  1994-07-02       Impact factor: 79.321

10.  Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain.

Authors:  A Akbar; Y Yiangou; P Facer; J R F Walters; P Anand; S Ghosh
Journal:  Gut       Date:  2008-02-05       Impact factor: 23.059

View more
  43 in total

Review 1.  Dietary Carbohydrates and Childhood Functional Abdominal Pain.

Authors:  Bruno P Chumpitazi; Robert J Shulman
Journal:  Ann Nutr Metab       Date:  2016-06-30       Impact factor: 3.374

2.  Feed your gut with caution!

Authors:  Vishal Singh; Beng San Yeoh; Matam Vijay-Kumar
Journal:  Transl Cancer Res       Date:  2016-09       Impact factor: 1.241

3.  Fructose malabsorption is not uncommon among patients with irritable bowel syndrome in India: a case-control study.

Authors:  Atul Sharma; Deepakshi Srivastava; Abhai Verma; Asha Misra; Uday C Ghoshal
Journal:  Indian J Gastroenterol       Date:  2014-07-29

4.  Urinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.

Authors:  Young Ah Goo; Kevin Cain; Monica Jarrett; Lynne Smith; Joachim Voss; Ernie Tolentino; Joyce Tsuji; Yihsuan S Tsai; Alexandre Panchaud; David R Goodlett; Robert J Shulman; Margaret Heitkemper
Journal:  J Proteome Res       Date:  2012-10-26       Impact factor: 4.466

Review 5.  Dietary fructose intolerance, fructan intolerance and FODMAPs.

Authors:  Amy Fedewa; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2014-01

Review 6.  Post-Infectious Irritable Bowel Syndrome.

Authors:  Yeong Yeh Lee; Chandramouli Annamalai; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2017-09-25

Review 7.  Contribution of diet to gut microbiota and related host cardiometabolic health: diet-gut interaction in human health.

Authors:  Yi Wan; Jun Tang; Jiaomei Li; Jie Li; Jihong Yuan; Fenglei Wang; Duo Li
Journal:  Gut Microbes       Date:  2020-01-21

Review 8.  Restriction of FODMAP in the management of bloating in irritable bowel syndrome.

Authors:  Wei Mon Wong
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

Review 9.  Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy.

Authors:  Massimo Bellini; Dario Gambaccini; Cristina Stasi; Maria Teresa Urbano; Santino Marchi; Paolo Usai-Satta
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

Review 10.  Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.

Authors:  Maria M Buckley; Siobhain M O'Mahony; Dervla O'Malley
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.